Associated Genetic Biomarkers
NCI Definition: A benign or malignant neoplasm involving the small or large intestine. 
Intestinal neoplasms most frequently harbor alterations in TP53, APC, KRAS, PIK3CA, and SMAD4 .
APC Mutation, TP53 Mutation, TP53 Missense, TP53 c.217-c.1178 Missense, and KRAS Mutation are the most common alterations in intestinal neoplasm .
There is 1 clinical trial for intestinal neoplasm, of which 1 is open and 0 are completed or closed. Of the trial that contains intestinal neoplasm as an inclusion criterion, 1 is phase 1 (1 open).
DPYD is the most frequent gene inclusion criterion for intestinal neoplasm clinical trials .
Capecitabine and eniluracil are the most common interventions in intestinal neoplasm clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.